Stēto builds remote-monitoring solutions and digital therapies to support daily medical care for people with diabetes. The company focuses on connecting patients with their medical teams through telemonitoring tools. Its telemonitoring solution was granted reimbursement by France’s Assurance Maladie two months ago and obtained a conformity certificate from the Agence du Numérique en Santé for interoperability and security. Stēto has joined the Agoranov incubator, signaling validation from the French tech ecosystem. The startup raised €1.2 million to accelerate development and scale deployment across France.

Total raised

$1M

Funding rounds

1

Latest round

Equity

Latest activity

Nov 2023